The downside of VC funding for biotech
World of DTC Marketing
JANUARY 24, 2022
Only about $2.2 A group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against H.R.3, The panel was hosted by the life sciences venture capital coalition Incubate and held at the National Press Club. ” VCs also don’t like price controls.
Let's personalize your content